pvt1 promotes the proliferation and invasion of gastric cancer by regulating autophagy through MAPK/ERK pathway

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200063936

Enrollment

Unknown

Registered

2022-09-21

Start date

2022-09-18

Completion date

Unknown

Last updated

2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

Observation group (gastric cancer tissue):None

Control group (normal adjacent tissue):None

Eligibility

Sex/Gender

All

Age

38 Years to 73 Years

Inclusion criteria

Inclusion criteria: 1. Aged 38-73 years; 2. Patients diagnosed with gastric cancer by pathological examination without metastasis of other organs and consistent with surgical indications.

Exclusion criteria

Exclusion criteria: 1. Postoperative pathological pTNM staging exceeded cTNM staging; 2. Intraoperative serous layer invasion of gastric cancer was found; 3. Patients with severe heart, liver and kidney dysfunction; 4. Patients with mental disorders; 5. Pregnant patients; 6. Patients with an expected survival of less than 3 months; 7. Patients with metastasis of other organs and unable to cooperate.

Design outcomes

Primary

Measure	Time frame
expression of PVT1;	—

Countries

China

Contacts

Public ContactLiang Chao

Li Huili Hospital

178402821@qq.com+86 18268483163

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026